Aleksandra Zoran Aracki-Trenkic

Prof. Dr. Aleksandra Zoran Aracki-Trenkic

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 August 2016 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
AAAleksandra Zoran Aracki-Trenkic
Aleksandra Zoran Aracki-Trenkic
DSDragan Stojanov
Dragan Stojanov
MTMilan Srbobran Trenkic
Milan Srbobran Trenkic
ZRZoran Radovanović
Zoran Radovanović
JIJelena Ignjatović
Jelena Ignjatović
MTMarija Trenkic
Marija Trenkic
Posterior reversible encephalopathy syndrome (PRES) is an obstetric emergency frequently occurring in a pregnant or puerperal woman, manifested with an acute headache, consciousness impairment, seizures, and visual deficits and is associated with white matter changes predominantly affecting the posterior parietal and occipital lobes of the brain. Apart from the above-described typical location of the changes, the most common atypical location involves the brain stem and basal ganglia. Since magnetic resonance imaging (MRI) is more sensitive and specific imaging technique compared to computerized tomography, establishing the diagnosis and follow-up in patients with PRES is based mainly on MRI findings. It is particularly important not to exclude PRES as a possible diagnosis when we have the appropriate clinical presentation accompanied by the atypical radiological findings, since this clinical-radiological syndrome can often be manifested with an atypical MRI image.

Verified
Journal Article
Open access
PDF file
JBJelena Bašić
Jelena Bašić
VMVuk D. Milošević
Vuk D. Milošević
BDBranka Djordjevic
Branka Djordjevic
Vladana StojiljkovicVladana Stojiljkovic
Vladana Stojiljkovic
MŽMilica Dejan Živanović
Milica Dejan Živanović
ISIvana Stojanovic
Ivana Stojanovic
This study investigated the diagnostic accuracy of plasma biomarkers—specifically, matrix metalloproteinase (MMP-9), tissue inhibitor of metalloproteinase (TIMP-1), CD147, and the MMP-/TIMP-1 ratio in patients with Alzheimer’s disease (AD) dementia. The research cohort comprised patients diagnosed with probable AD dementia and a control group of cognitively unimpaired (CU) individuals. Neuroradiological assessments included brain magnetic resonance imaging (MRI) following dementia protocols, with subsequent volumetric analysis. Additionally, cerebrospinal fluid (CSF) AD biomarkers were classified using the A/T/N system, and apolipoprotein E (APOE) ε4 carrier status was determined. Findings revealed elevated plasma levels of MMP-9 and TIMP-1 in AD dementia patients compared to CU individuals. Receiver operating characteristic (ROC) curve analysis demonstrated significant differences in the areas under the curve (AUC) for MMP-9 (p < 0.001) and TIMP-1 (p < 0.001). Notably, plasma TIMP-1 levels were significantly lower in APOE ε4+ patients than in APOE ε4− patients (p = 0.041). Furthermore, APOE ε4+ patients exhibited reduced hippocampal volume, particularly in total, right, and left hippocampal measurements. TIMP-1 levels exhibited a positive correlation, while the MMP-9/TIMP-1 ratio showed a negative correlation with hippocampal volume parameters. This study sheds light on the potential use of TIMP-1 as a diagnostic marker and its association with hippocampal changes in AD.

1 January 2017 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
JPJasmina Popovic
Jasmina Popovic
SDSonja Pop-Trajkovic Dinic
Sonja Pop-Trajkovic Dinic
MSMilan Stefanović
Milan Stefanović
MTMilan Srbobran Trenkic
Milan Srbobran Trenkic
AAAleksandra Zoran Aracki-Trenkic
Aleksandra Zoran Aracki-Trenkic
Introduction. Dysgerminomas are germ cell ovarian tumors. They affect young females, prevalently during childhood. The problem arises when dysgerminoma is diagnosed in women of reproductive age who have never given birth and require a surgical procedure. Case outline. A 28-year-old patient was admitted to hospital in week 26 of her first pregnancy. The reason for patient hospitalization was the growth of the isthmic myoma diagnosed by her obstetriciangynecologist in the primary care unit. By examining the medical history of the patient, the following was revealed: A year and a half before pregnancy she was diagnosed with left ovary dysgerminoma. The patient?s medical history led us to conclude that uterine myoma was a misdiagnosis and that the actual diagnosis was dysgerminoma of the right ovary. The surgery was performed after the fetal viability had been achieved. Conclusion. Malignant ovarian tumours may occur in young women during pregnancy and increase in size significantly in a short period of time, although their recurrence is not expected in such a short period of time after surgical treatment. This poses a great challenge for obstetricians.

20 June 2016
Verified
Closed access
AAAleksandra Zoran Aracki-Trenkic
Aleksandra Zoran Aracki-Trenkic
DSDragan Stojanov
Dragan Stojanov
MTMilan Trenkić
Milan Trenkić
ZRZoran Radovanović
Zoran Radovanović
JIJelena Ignjatović
Jelena Ignjatović
MTMarija Trenkić-Bozinović
Marija Trenkić-Bozinović

16 August 2014 in Open Medicine
Verified
Journal Article
Open access
JIJelena Ignjatović
Jelena Ignjatović
DSDragan Stojanov
Dragan Stojanov
NSNebojsa Stojanovic
Nebojsa Stojanovic
SSStefan Stefanovic
Stefan Stefanovic
DSDaniela Benedeto Stojanov
Daniela Benedeto Stojanov
NINebojša Ignjatović
Nebojša Ignjatović